SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-096192
Filing Date
2024-04-15
Accepted
2024-04-15 16:06:06
Documents
19
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d21304ddef14a.htm   iXBRL DEF 14A 792521
6 GRAPHIC g21304g01g01.jpg GRAPHIC 273231
7 GRAPHIC g21304g02g02.jpg GRAPHIC 245616
8 GRAPHIC g21304g02m02.jpg GRAPHIC 31438
9 GRAPHIC g21304g31l03.jpg GRAPHIC 105252
10 GRAPHIC g21304g76i41.jpg GRAPHIC 104213
  Complete submission text file 0001193125-24-096192.txt   3382679

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20231231.xsd EX-101.SCH 5037
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20231231_def.xml EX-101.DEF 4850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20231231_lab.xml EX-101.LAB 7257
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20231231_pre.xml EX-101.PRE 4107
22 EXTRACTED XBRL INSTANCE DOCUMENT d21304ddef14a_htm.xml XML 220038
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39323 | Film No.: 24844693
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)